Wang Fanglin, Wang Qiao, Zhao Yu, Tian Zhiyu, Chang Shijie, Tong Hao, Liu Ningwei, Bai Shuling, Li Xiang, Fan Jun
Department of Tissue Engineering, School of Intelligent Medicine, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.
Department of Plastic Surgery, Shengjing Hospital, Affiliated Hospital of China Medical University, No.36 Sanhao Street, Heping area, Shenyang, Liaoning 110004, PR China.
Acta Biomater. 2023 Jan 1;155:644-653. doi: 10.1016/j.actbio.2022.09.070. Epub 2022 Oct 4.
Adipose-derived mesenchymal stem cells (ADSCs) are multipotent stromal cells and play huge role in forming and repairing bone tissues. Emerging evidence shows that MicroRNAs (miRNAs) are involved in ADSCs differentiation. Here, we explored the role of miR-150-5p and its related mechanisms in ADSCs osteogenesis. Real-time PCR was used to determine miR-150-5p expression during ADSCs osteogenesis. miR-150-5p inhibitors, miR-150-5p ADV or short hairpin RNA (shRNA) of Notch3 were transfected to ADSCs for analyzing the effects on osteogenesis. The mixture of hydroxyapatite/tricalcium phosphate (HA/TCP) ceramic powders and transfected ADSCs was implanted into BALB/C nude mice. Micro-CT and histological methods were performed to evaluate the new bone formation. Compared with negative control (NC) and miR-150-5p overexpression, inhibition of miR-150-5p increased ADSCs osteogenesis by regulating Notch3. MiR-150-5p overexpression decreased the expression of pFAK, pERK1/2, and RhoA, while these were up-regulated when miR-150-5p was inhibited, or notch3 was silenced. Furthermore, miR-150-5p inhibition partially reversed the suppression effect of notch3 knockdown on osteogenesis in vitro and in vivo. This study demonstrated the critical function of miR-150-5p during osteogenesis. The combination of ADSCs with miR-150-5p inhibition and HA/TCP might be a promising strategy for bone damage repair. STATEMENT OF SIGNIFICANCE: Osteoporosis is a common chronic metabolic bone disease in humans. Bone tissue engineering based on mesenchymal stem cells, biomaterials, and growth factors, provides a promising way to treat osteoporosis and bone defects. ADSCs commonly differentiate into adipose cells, they can also differentiate into osteogenic cell lineages. Nucleic acids and protein have usually been considered as regulators of ADSCs osteogenic differentiation. In the current study, we demonstrated the combination of ADSCs with miR-150-5p inhibition and hydroxyapatite/tricalcium phosphate ceramic powders enhanced bone regeneration. Furthermore, miR-150-5p/Notch3 axis regulating osteogenesis via the FAK/ERK1/2 and RhoA pathway was assessed. The current study showed the application of ADSCs in bone regeneration might be a promising strategy for osteoporosis and bone damage repairing.
脂肪来源的间充质干细胞(ADSCs)是多能基质细胞,在骨组织的形成和修复中发挥着重要作用。新出现的证据表明,微小RNA(miRNAs)参与了ADSCs的分化。在此,我们探讨了miR-150-5p在ADSCs成骨过程中的作用及其相关机制。采用实时定量聚合酶链反应(Real-time PCR)检测ADSCs成骨过程中miR-150-5p的表达。将miR-150-5p抑制剂、miR-150-5p腺病毒载体(ADV)或Notch3短发夹RNA(shRNA)转染至ADSCs,以分析其对成骨的影响。将羟基磷灰石/磷酸三钙(HA/TCP)陶瓷粉末与转染后的ADSCs混合物植入BALB/C裸鼠体内。采用显微计算机断层扫描(Micro-CT)和组织学方法评估新骨形成情况。与阴性对照(NC)和miR-150-5p过表达相比,抑制miR-150-5p可通过调节Notch3促进ADSCs成骨。miR-150-5p过表达降低了磷酸化粘着斑激酶(pFAK)、磷酸化细胞外信号调节激酶1/2(pERK1/2)和RhoA的表达,而当miR-150-5p被抑制或Notch3被沉默时,这些蛋白的表达上调。此外,抑制miR-150-5p可部分逆转Notch3基因敲低对体内外成骨的抑制作用。本研究证明了miR-150-5p在成骨过程中的关键作用。ADSCs与抑制miR-150-5p和HA/TCP的联合应用可能是一种有前景的骨损伤修复策略。
骨质疏松症是人类常见的慢性代谢性骨病。基于间充质干细胞、生物材料和生长因子的骨组织工程为治疗骨质疏松症和骨缺损提供了一种有前景的方法。ADSCs通常分化为脂肪细胞,也可分化为成骨细胞系。核酸和蛋白质通常被认为是ADSCs成骨分化的调节因子。在本研究中,我们证明了ADSCs与抑制miR-150-5p和羟基磷灰石/磷酸三钙陶瓷粉末的联合应用可增强骨再生。此外,评估了miR-150-5p/Notch3轴通过FAK/ERK1/2和RhoA途径调节成骨的作用。本研究表明,ADSCs在骨再生中的应用可能是一种治疗骨质疏松症和骨损伤修复的有前景的策略。